BGMS logo

Bio Green Med Solution, Inc.

BGMS
Healthcare|Medical - Pharmaceuticals|MY
$0.86
-0.01 (-0.58%)
DCF Value
$4.74
Tangible Book / Share
$1.00
Cash / Share
$0.68

Earnings History

Next report: Nov 18, 2026
Report DateEPS ActualEPS Est.Revenue ActualRevenue Est.
Aug 13, 2026$-0.08—$336.0K—
May 14, 2026$-0.04—$778.0K—
Mar 30, 2026$-2.21$-72.00$666.0K$25.0K
Nov 13, 2025$-1.31$-72.00$81.0K$25.0K
Aug 13, 2025$-0.98$-72.00—$25.0K
May 15, 2025$-0.09$-69.60—$25.0K
Apr 2, 2025$-79.20$-69.60—$10.0K
Nov 12, 2024$-43.20$-129.60$10.0K$10.0K

News

Reviewing MSC Industrial Direct (NYSE:MSM) & Cyclacel Pharmaceuticals (NASDAQ:BGMS)

Cyclacel Pharmaceuticals (NASDAQ: BGMS - Get Free Report) and MSC Industrial Direct (NYSE: MSM - Get Free Report) are both industrials companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership. Profitability This table compares Cyclacel Pharmaceuticals and

Nov 6, 2026defenseworld.net
Cyclacel Pharmaceuticals (NASDAQ:BGMS) and EquipmentShare.com (NASDAQ:EQPT) Financial Contrast

EquipmentShare.com (NASDAQ: EQPT - Get Free Report) and Cyclacel Pharmaceuticals (NASDAQ: BGMS - Get Free Report) are both industrials companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings. Profitability This table compares EquipmentShare.com and Cyclacel Pharmaceuticals' net

Oct 13, 2026defenseworld.net
$HAREHOLDER ALERT - The M&A Class Action Firm Continues to Investigate the Merger— ATKR, BZH, BGMS and CBAN

NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating:

Sep 30, 2026globenewswire.com
Cyclacel Pharmaceuticals, Inc. (NASDAQ:BGMS) Shares Shorted: Short Interest Up 160.2% in September

Cyclacel Pharmaceuticals, Inc. (NASDAQ: BGMS - Get Free Report) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 90,785 shares, a growth of 160.2% from the August 31st total of 34,897 shares. Currently, 2.2% of the shares of the stock are short sold. Based

Sep 28, 2026defenseworld.net
EQUITY ALERT: The M&A Class Action Firm Launches Inquiry for the Merger— ATKR, BGMS, BOW and FTHM

NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating

Sep 8, 2026globenewswire.com
BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

KUALA LUMPUR, MALAYSIA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; "BGMS" or the "Company"), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced second quarter financial results and provided a business update.

Aug 12, 2026globenewswire.com